Skip to navigation Skip to content ENPICOMENPICOMENPICOM
Menu
  • Why ENPICOM
  • Software & Services
    • Software
      • Platform overview
      • Data foundation
      • Automation
      • Discovery tooling
      • AI integration
      Services
      • Analysis services
      • Antibody humanization
  • Use cases
    • AI integration
      • Model deployment
      Biologics research
      • Developability assessment
      • Hit selection
      • Hit expansion
      • Enrichment analysis
  • Knowledge center
    • News and blogs
    • Resources
  • Company
    • About us
    • Contact us
Schedule a demo
Schedule a demo
  1. Home
  2. Company news
  3. Page 2

Category: Company news

All Company news Press releases

ENPICOM introduces a powerful liability prediction solution to de-risk antibody development

The IGX Platform empowers researchers to accurately predict exposed liabilities for thousands of sequences at the same time using high-throughput structural modeling.

September 7, 2021October 25, 2024
All Company news

ENPICOM is featured among the top 50 fastest growing Data Science SMEs in the Netherlands

The Florijnz Data Science Top 50 report is out! We’re excited to be recognized as one of the fastest-growing players in the Data Science market for small and medium-sized enterprises in the Netherlands.

August 25, 2021September 14, 2024
All Company news Press releases

ENPICOM to integrate renowned structural antibody prediction tools developed at the University of Oxford

The IGX Platform integrates SAbPred, developed at the University of Oxford, to support high-throughput de-risking of antibody discovery.

June 10, 2021October 25, 2024
All Company news Press releases

Zai Lab selects ENPICOM’s IGX Platform to leverage new NGS-powered antibody discovery workflows

ENPICOM, an innovative bioinformatics software engineering company, announced today that Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative, research-based, commercial-stage biopharmaceutical company based in China and the U.S., has signed a subscription agreement for ENPICOM’s IGX Platform.

May 27, 2021October 16, 2024
All Company news Press releases

ENPICOM introduces an end-to-end solution for fast and efficient antibody discovery

ENPICOM announces a new Antibody Discovery Module, empowering scientists and service providers in the antibody discovery field to analyze Sanger and NGS data independently.

January 28, 2021October 25, 2024
All Company news

ENPICOM is now a corporate sponsor of The Antibody Society

The Antibody Society is an international non-profit association, founded in 2007, to represent individuals and organizations involved in antibody-related research and development. We are now pleased to announce an official corporate sponsorship of The Antibody Society.

October 8, 2020September 14, 2024
  • 2 / 2
  • 1
  • 2

Sidebar

Recent Posts

  • MLOps: The unsung hero of AI-powered biologics discoveryJanuary 7, 2025
  • Unlocking the potential of AI in biologics discovery: Applications, adoption challenges, and the roadmap to successDecember 12, 2024
  • ENPICOM launches unified bioinformatics platform for lab and AI scientistsOctober 1, 2024

Tags

Follow us

  • LinkedIn
ENPICOM logo
Useful links
  • Home
  • Why ENPICOM
  • Platform overview
  • News & blogs
  • Resources
  • Privacy policy
  • Terms and conditions
Contact us
  • LinkedIn
  • Email
  • Careers

© 2025 ENPICOM.com

Top
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}